Who backs Avenzo Therapeutics?
15 investors| Investor | Type |
|---|---|
| New Enterprise Associates | Venture capital |
| OrbiMed | Growth equity |
| Sands Capital | Growth equity |
| Foresite Capital | Venture capital |
| INCE Capital | Venture capital |
| SR One Capital Management | Other |
| Surveyor Capital | Hedge fund |
| Deep Track Capital | Venture capital |
| Lilly Asia Ventures | Venture capital |
| Delos Capital Partners | — |
| + 5 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Avenzo Therapeutics investors
15 investors are on record for Avenzo Therapeutics, including New Enterprise Associates, OrbiMed, Sands Capital and Foresite Capital. By type, the record holds 5 venture capital firms, 2 growth equity firms and 1 hedge fund. The early-stage round in Aug 2025 drew 20 investors.
Free account
More of Avenzo Therapeutics with a free account
- ·The complete investor list: 15 names
- ·Watch Avenzo Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 15 firms already write checks for companies like Avenzo Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View